Canton Strategic Holdings CNTN
NASDAQ CNTN
$2.28 +0.03 (+1.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

Canton Strategic Holdings (CNTN) Long-Term Deferred Tax (2024)

Canton Strategic Holdings' (CNTN) quarterly Long-Term Deferred Tax came in at $10.2 million in Q4 2024.

Analysis

Canton Strategic Holdings (CNTN) Long-Term Deferred Tax (2024) Analysis & Trends

Canton Strategic Holdings (CNTN) has 1 years of Long-Term Deferred Tax data on file, last reported at $10.2 million in Q4 2024.

  • Quarterly Long-Term Deferred Tax changed N/A year-over-year to $10.2 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $10.2 million (changed N/A YoY) and the FY2024 annual result came in at $10.2 million, changed N/A from the prior year.
  • Long-Term Deferred Tax steadied at $10.2 million in Q4 2024.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $10.2 million in Q4 2024 to a low of $10.2 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Canton Strategic Holdings 493.37 Mn 493.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 10.19 Mn